AIKMO MEDICAL LIMITEDActive
Key figures
Ratios
2024/25Balance sheet structure
Dividends
from the accountsDividends paid in the financial year: £167,200 (25% of the profit for the year).
Filed accounts2022/23–2024/25
| 2022/23 | 2023/24 | 2024/25 | |
|---|---|---|---|
| Turnover | 2,440,175 | 2,481,652 | 2,815,998 |
| Profit for the year | 304,165 | 663,690 | 572,742 |
| Cash at bank and in hand | 321,353 | 401,789 | 119,450 |
| Total assets | 6,781,056 | 7,175,383 | 7,563,117 |
| Total liabilities | 3,647,437 | 3,537,250 | — |
| Net assets / total equity | 3,027,620 | 3,524,110 | 3,897,853 |
| Average number of employees | 55 | 55 | 58 |
| Average pay (per year) | 19,422 | 19,482 | — |
| Dividends paid | -373,700 | -167,200 | — |
A dash (—) means no accounts were filed for that year or the item is not in the accounts; 0 is a zero stated in the accounts. Small companies usually file only a balance sheet, so the profit and loss account is often missing.
Principal activity
Accounts 2025The company's principal activity continues to be that of operation of a care home.
As described in the company's latest filed accounts.
Summary: AIKMO MEDICAL LIMITED
Company
AIKMO MEDICAL LIMITED is a private limited company registered with Companies House under company number 03029559. It was incorporated on 6 Mar 1995. Its status is active. The registered office is in Sale (M33). Its nature of business (SIC 2007) is residential nursing care facilities (87100).
Accounts
The latest accounts in the database are for 2024/25 (period ending 31 Mar 2025); the company files small company accounts. Turnover was £2,815,998. Profit for the year was £572,742. Net assets were £3,897,853, up 10.6% on the previous year. Cash at bank and in hand was £119,450. The company had an average of 58 employees. Figures are available for 3 financial years (2022/23–2024/25).
Control and charges
One person with significant control is registered. 7 of 12 registered charges are outstanding.
Filing deadlines
The next accounts are due by 31 Dec 2026. The next confirmation statement is due by 2 Mar 2027.